| Overview |
| bsm-90023r-50µL |
| NDUFS3 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human NDUFS3 |
| 200-264/264 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 4722 |
| O75489 |
| NDUFS3; NADH:Ubiquinone Oxidoreductase Core Subunit S3; NADH Dehydrogenase [Ubiquinone] Iron-Sulfur Protein 3 Mitochondrial; CI-30; NADH Dehydrogenase (Ubiquinone) Fe-S Protein 3 30kDa (NADH-Coenzyme Q Reductase); NADH-Ubiquinone Oxidoreductase 30 KDa Subunit; Complex I 30kDa Subunit; Complex I-30kD; CI-30kD; NADH Dehydrogenase (Ubiquinone) Fe-S Protein 3 (30kD) (NADH-Coenzyme Q Reductase); NADH Dehydrogenase-Ubiquinone 30 KDa Subunit; EC 1.6.99.5; EC 7.1.1.2; MC1DN8 |
| Cell Line: HeLa Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |